Depending on a variety of factors, there are various options for the treatment of genitourinary cancers (included bladder, kidney, and prostate cancers) including immunotherapy. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC...
2020_Immuno_GU.pdf
Immunotherapy has revolutionized the treatment of certain types of melanoma and other skin cancers. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), provides information on melanoma and other skin cancers, the immune system,...
2020 Immuno Melanoma-Final.pdf
The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as...
With cutting-edge data regularly emerging from conferences and new FDA approvals, keeping updated with the latest cancer immunotherapy research is an arduous task for a practicing clinician. To complement and expand upon the live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is proud to...
2 attachments
Edited By: Marc S. Ernstoff, MD – Roswell Park Comprehensive Cancer Center Igor Puzanov, MD, MSCI, FACP – Roswell Park Comprehensive Cancer Center Caroline Robert, MD, PhD – Institut Gustave Roussy Adi Diab, MD – The University of Texas MD Anderson Cancer Center Peter Hersey, MD, PhD –...
Immunotherapy is revolutionizing how doctors treat certain types of cancer. Sometimes referred to as biologic therapy or biotherapy, immunotherapy harnesses the potential of the body's own immune system to fight cancer. Training the immune system to respond to cancer has the potential for a more...
The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 215: Myeloid Derived Suppressive Populations" during the SITC 2018 Annual Meeting on November 10, 2018. Available here are the presentation slides and video from the session. 33 rd Annual Meeting Organizers ...
6 attachments
The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 210: Advances in Immunotherapy of GU Tumors" during the SITC 2018 Annual Meeting on November 10, 2018. Available here are the presentation slides and video from the session. 33 rd Annual Meeting Organizers ...
The Society for Immunotherapy of Cancer (SITC) hosted "Rapid Oral Abstracts (Saturday)" during SITC 2018 Annual Meeting on November 10, 2018. Available here are the presentation slides and video from the session. 33 rd Annual Meeting Organizers Crystal L. Mackall, MD – Stanford...
16 attachments
The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 106: Cytokines Reinvented" during the SITC 2018 Annual Meeting on November 9, 2018. Available here are the presentation slides and video from the session. 33 rd Annual Meeting Organizers Crystal L. Mackall,...
12 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us